<DOC>
	<DOCNO>NCT02933866</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Vehicle-Controlled , Parallel-Design , Multiple-Site , Phase III Clinical Study Evaluate Efficacy Safety DSXS topical product Patients Mild Severe Scalp Psoriasis</brief_summary>
	<brief_title>Phase III Clinical Study Patients With Mild Severe Scalp Psoriasis</brief_title>
	<detailed_description>To evaluate therapeutic efficacy safety DSXS topical product ( Taro Pharmaceuticals , U.S.A. , Inc. ) compare Vehicle topical product ( Taro Pharmaceuticals , U.S.A. , Inc. ) patient mild severe scalp psoriasis .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male nonpregnant , nonlactating female 18 year age old . Females pregnant , lactate likely become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>